Cargando…
Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
Metformin is the most widely used antidiabetic drug because of its proven efficacy and limited secondary effects. Interestingly, recent studies have reported that metformin can block the growth of different tumor types. Here, we show that metformin exerts antiproliferative effects on melanoma cells,...
Autores principales: | Tomic, T, Botton, T, Cerezo, M, Robert, G, Luciano, F, Puissant, A, Gounon, P, Allegra, M, Bertolotto, C, Bereder, J-M, Tartare-Deckert, S, Bahadoran, P, Auberger, P, Ballotti, R, Rocchi, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186904/ https://www.ncbi.nlm.nih.gov/pubmed/21881601 http://dx.doi.org/10.1038/cddis.2011.86 |
Ejemplares similares
-
CD271 is an imperfect marker for melanoma initiating cells
por: Cheli, Yann, et al.
Publicado: (2014) -
SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells
por: Ohanna, Mickaël, et al.
Publicado: (2014) -
Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib
por: Lehraiki, Abdelali, et al.
Publicado: (2015) -
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance
por: Diazzi, Serena, et al.
Publicado: (2023) -
The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion
por: Fenouille, Nina, et al.
Publicado: (2012)